(BF-A) Brown-Forman - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1156371007
Stock: Whiskey, Bourbon, Tequila, Gin, Brandy
Total Rating 42
Risk 86
Buy Signal -0.07
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.00% |
| Yield on Cost 5y | 1.43% |
| Yield CAGR 5y | -14.78% |
| Payout Consistency | 87.7% |
| Payout Ratio | 53.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 32.4% |
| Relative Tail Risk | -3.69% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.01 |
| Alpha | -11.58 |
| Character TTM | |
|---|---|
| Beta | 0.523 |
| Beta Downside | 0.282 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.64% |
| CAGR/Max DD | -0.34 |
Description: BF-A Brown-Forman January 02, 2026
Brown-Forman (NYSE: BF-A) is a global producer and marketer of alcoholic beverages, encompassing distilled spirits, wines, and ready-to-drink (RTD) cocktails. Its portfolio is anchored by premium brands such as Jack Daniel’s, Woodford Reserve, Old Forester, Herradura, and el Jimador, and it also offers contract bottling, used barrel sales, and bulk whiskey and wine services to distributors, state and provincial governments, and retail partners worldwide.
In FY 2023 the company generated approximately $4.3 billion in net sales, with an adjusted operating margin near 30 % and free cash flow of $1.2 billion, underscoring its high-margin, cash-generative business model. Key growth drivers include the expanding RTD category (which grew ~12 % YoY) and sustained premium-spirit demand in the United States, while foreign-exchange exposure-particularly the euro and Mexican peso-remains a material risk factor for international earnings.
For a deeper, data-driven look at Brown-Forman’s valuation metrics and scenario analysis, you might find the ValueRay platform worth a quick check.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 810.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 1.92 > 1.0 |
| NWC/Revenue: 71.78% < 20% (prev 64.80%; Δ 6.98% < -1%) |
| CFO/TA 0.09 > 3% & CFO 761.0m > Net Income 810.0m |
| Net Debt (2.33b) to EBITDA (1.21b): 1.92 < 3 |
| Current Ratio: 2.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (472.6m) vs 12m ago -0.10% < -2% |
| Gross Margin: 59.17% > 18% (prev 0.59%; Δ 5858 % > 0.5%) |
| Asset Turnover: 47.05% > 50% (prev 48.96%; Δ -1.91% > 0%) |
| Interest Coverage Ratio: 10.30 > 6 (EBITDA TTM 1.21b / Interest Expense TTM 109.0m) |
Altman Z'' 6.29
| A: 0.34 (Total Current Assets 4.21b - Total Current Liabilities 1.42b) / Total Assets 8.22b |
| B: 0.59 (Retained Earnings 4.89b / Total Assets 8.22b) |
| C: 0.14 (EBIT TTM 1.12b / Avg Total Assets 8.28b) |
| D: 1.15 (Book Value of Equity 4.72b / Total Liabilities 4.09b) |
| Altman-Z'' Score: 6.29 = AAA |
Beneish M -2.96
| DSRI: 1.14 (Receivables 1.04b/954.0m, Revenue 3.89b/4.08b) |
| GMI: 1.00 (GM 59.17% / 59.21%) |
| AQI: 0.96 (AQ_t 0.35 / AQ_t-1 0.37) |
| SGI: 0.95 (Revenue 3.89b / 4.08b) |
| TATA: 0.01 (NI 810.0m - CFO 761.0m) / TA 8.22b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of BF-A shares?
As of February 07, 2026, the stock is trading at USD 29.83 with a total of 191,625 shares traded.
Over the past week, the price has changed by +7.19%, over one month by +13.64%, over three months by +13.84% and over the past year by -2.17%.
Over the past week, the price has changed by +7.19%, over one month by +13.64%, over three months by +13.84% and over the past year by -2.17%.
Is BF-A a buy, sell or hold?
Brown-Forman has no consensus analysts rating.
What are the forecasts/targets for the BF-A price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 26.4 | -11.6% |
BF-A Fundamental Data Overview February 04, 2026
P/E Trailing = 16.1287
P/E Forward = 16.8634
P/S = 3.285
P/B = 3.1183
P/EG = 5.0198
Revenue TTM = 3.89b USD
EBIT TTM = 1.12b USD
EBITDA TTM = 1.21b USD
Long Term Debt = 2.07b USD (from longTermDebt, last quarter)
Short Term Debt = 575.0m USD (from shortTermDebt, last quarter)
Debt = 2.65b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.33b USD (from netDebt column, last quarter)
Enterprise Value = 15.10b USD (12.78b + Debt 2.65b - CCE 319.0m)
Interest Coverage Ratio = 10.30 (Ebit TTM 1.12b / Interest Expense TTM 109.0m)
EV/FCF = 24.76x (Enterprise Value 15.10b / FCF TTM 610.0m)
FCF Yield = 4.04% (FCF TTM 610.0m / Enterprise Value 15.10b)
FCF Margin = 15.67% (FCF TTM 610.0m / Revenue TTM 3.89b)
Net Margin = 20.80% (Net Income TTM 810.0m / Revenue TTM 3.89b)
Gross Margin = 59.17% ((Revenue TTM 3.89b - Cost of Revenue TTM 1.59b) / Revenue TTM)
Gross Margin QoQ = 59.56% (prev 59.74%)
Tobins Q-Ratio = 1.84 (Enterprise Value 15.10b / Total Assets 8.22b)
Interest Expense / Debt = 0.98% (Interest Expense 26.0m / Debt 2.65b)
Taxrate = 19.71% (55.0m / 279.0m)
NOPAT = 901.6m (EBIT 1.12b * (1 - 19.71%))
Current Ratio = 2.97 (Total Current Assets 4.21b / Total Current Liabilities 1.42b)
Debt / Equity = 0.64 (Debt 2.65b / totalStockholderEquity, last quarter 4.13b)
Debt / EBITDA = 1.92 (Net Debt 2.33b / EBITDA 1.21b)
Debt / FCF = 3.82 (Net Debt 2.33b / FCF TTM 610.0m)
Total Stockholder Equity = 3.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.79% (Net Income 810.0m / Total Assets 8.22b)
RoE = 20.33% (Net Income TTM 810.0m / Total Stockholder Equity 3.98b)
RoCE = 18.54% (EBIT 1.12b / Capital Employed (Equity 3.98b + L.T.Debt 2.07b))
RoIC = 13.42% (NOPAT 901.6m / Invested Capital 6.72b)
WACC = 6.63% (E(12.78b)/V(15.42b) * Re(7.84%) + D(2.65b)/V(15.42b) * Rd(0.98%) * (1-Tc(0.20)))
Discount Rate = 7.84% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.78%
[DCF Debug] Terminal Value 83.14% ; FCFF base≈549.2m ; Y1≈539.3m ; Y5≈550.5m
Fair Price DCF = 64.79 (EV 13.25b - Net Debt 2.33b = Equity 10.92b / Shares 168.6m; r=6.63% [WACC]; 5y FCF grow -2.73% → 2.90% )
EPS Correlation: 7.65 | EPS CAGR: -3.42% | SUE: -0.27 | # QB: 0
Revenue Correlation: -37.44 | Revenue CAGR: 0.10% | SUE: 0.43 | # QB: 0
P/E Forward = 16.8634
P/S = 3.285
P/B = 3.1183
P/EG = 5.0198
Revenue TTM = 3.89b USD
EBIT TTM = 1.12b USD
EBITDA TTM = 1.21b USD
Long Term Debt = 2.07b USD (from longTermDebt, last quarter)
Short Term Debt = 575.0m USD (from shortTermDebt, last quarter)
Debt = 2.65b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.33b USD (from netDebt column, last quarter)
Enterprise Value = 15.10b USD (12.78b + Debt 2.65b - CCE 319.0m)
Interest Coverage Ratio = 10.30 (Ebit TTM 1.12b / Interest Expense TTM 109.0m)
EV/FCF = 24.76x (Enterprise Value 15.10b / FCF TTM 610.0m)
FCF Yield = 4.04% (FCF TTM 610.0m / Enterprise Value 15.10b)
FCF Margin = 15.67% (FCF TTM 610.0m / Revenue TTM 3.89b)
Net Margin = 20.80% (Net Income TTM 810.0m / Revenue TTM 3.89b)
Gross Margin = 59.17% ((Revenue TTM 3.89b - Cost of Revenue TTM 1.59b) / Revenue TTM)
Gross Margin QoQ = 59.56% (prev 59.74%)
Tobins Q-Ratio = 1.84 (Enterprise Value 15.10b / Total Assets 8.22b)
Interest Expense / Debt = 0.98% (Interest Expense 26.0m / Debt 2.65b)
Taxrate = 19.71% (55.0m / 279.0m)
NOPAT = 901.6m (EBIT 1.12b * (1 - 19.71%))
Current Ratio = 2.97 (Total Current Assets 4.21b / Total Current Liabilities 1.42b)
Debt / Equity = 0.64 (Debt 2.65b / totalStockholderEquity, last quarter 4.13b)
Debt / EBITDA = 1.92 (Net Debt 2.33b / EBITDA 1.21b)
Debt / FCF = 3.82 (Net Debt 2.33b / FCF TTM 610.0m)
Total Stockholder Equity = 3.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.79% (Net Income 810.0m / Total Assets 8.22b)
RoE = 20.33% (Net Income TTM 810.0m / Total Stockholder Equity 3.98b)
RoCE = 18.54% (EBIT 1.12b / Capital Employed (Equity 3.98b + L.T.Debt 2.07b))
RoIC = 13.42% (NOPAT 901.6m / Invested Capital 6.72b)
WACC = 6.63% (E(12.78b)/V(15.42b) * Re(7.84%) + D(2.65b)/V(15.42b) * Rd(0.98%) * (1-Tc(0.20)))
Discount Rate = 7.84% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.78%
[DCF Debug] Terminal Value 83.14% ; FCFF base≈549.2m ; Y1≈539.3m ; Y5≈550.5m
Fair Price DCF = 64.79 (EV 13.25b - Net Debt 2.33b = Equity 10.92b / Shares 168.6m; r=6.63% [WACC]; 5y FCF grow -2.73% → 2.90% )
EPS Correlation: 7.65 | EPS CAGR: -3.42% | SUE: -0.27 | # QB: 0
Revenue Correlation: -37.44 | Revenue CAGR: 0.10% | SUE: 0.43 | # QB: 0